藥物研發資訊學的全球市場
市場調查報告書
商品編碼
1199072

藥物研發資訊學的全球市場

Drug Discovery Informatics

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球藥物研發資訊學的市場規模預測將從2022年的23億美元到2030年達到48億美元,在2022年~2030年間預計將以年複合成長率9.8%的速度成長。

本報告提供全球藥物研發資訊學市場相關調查分析,提供市場趨勢與促進因素,地區分析,競爭情形等資訊。

調查對象企業範例(全29公司):

  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他的歐洲
  • 亞太地區
  • 其他地區

第4章 競爭

簡介目錄
Product Code: MCP11646

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Drug Discovery Informatics Market to Reach $4.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Drug Discovery Informatics estimated at US$2.3 Billion in the year 2022, is projected to reach a revised size of US$4.8 Billion by 2030, growing at aCAGR of 9.8% over the period 2022-2030. Software, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 11% CAGR for the next 8-year period.

The U.S. Market is Estimated at $661.9 Million, While China is Forecast to Grow at 9.2% CAGR

The Drug Discovery Informatics market in the U.S. is estimated at US$661.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$824.6 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Select Competitors (Total 29 Featured):

  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Drug Discovery Informatics: A Prelude
    • Drug Discovery Informatics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market
    • Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019
    • Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
    • Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market
    • Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics
    • Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics
    • The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine
    • Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
    • Cloud Computing Emerges to Play a Key Role in Bioinformatics
    • Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics
    • Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
    • Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024
    • Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics
    • Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025
    • Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics
    • Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics
    • Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 25: World Drug Discovery Informatics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Canada 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Japan 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Japan 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: China 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: China 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: China 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Europe 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Europe 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • FRANCE
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: France 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: France 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: France 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Germany 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Germany 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Germany 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Italy 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Italy 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: UK 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: UK 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: UK 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Rest of World 8-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2023 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Rest of World 8-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2023 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of World 8-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2023 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of World 8-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION